Epdox-CV is a powerful, broad-spectrum antibiotic oral suspension that combines Cefpodoxime Proxetil and Clavulanic Acid. This synergistic formulation is designed to treat a wide range of bacterial infections effectively in pediatric patients. Cefpodoxime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Clavulanate, a beta-lactamase inhibitor, enhances its efficacy by overcoming bacterial resistance.
Key Features:
Composition: Cefpodoxime Proxetil + Clavulanate Potassium
Form: Oral Suspension
Indications: Effective in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, ENT infections, and more.
Pediatric Use: Specially formulated for children, with a palatable taste for better compliance.
Benefits:
Combats resistant bacterial strains
Broad-spectrum coverage
Convenient pediatric dosing
Clinically proven efficacy and safety
Dosage & Administration:
As prescribed by the physician, based on the child’s age, weight, and severity of infection.
Storage:
Store in a cool, dry place. Reconstituted suspension should be kept refrigerated and used within the recommended duration.
